Sign inJoin waitlistJoin the waitlist

EP

Elizabeth Poplin

Medical Oncology

Credentials: · ·

History

Medical Oncology
1979–1981
Internal Medicine
1976–1979
University of Massachusetts Medical School
1972–1976

Research

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab
Journal of Clinical Oncology · 2007 · 969 citations
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel
Journal of Clinical Oncology · 2001 · 365 citations
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic…
Journal of Clinical Oncology · 2009 · First of 12 authors · Corresponding · 357 citations

LB
Laurence Baker
9 papers
Salma Jabbour
7 papers
JA
Joseph Aisner
6 papers
RM
Rebecca Moss
6 papers
Janice Mehnert
5 papers
JM
John Macdonald
5 papers
MV
Manuel Valdivieso
5 papers
Mark Stein
5 papers
Antoinette Tan
4 papers
Darren Carpizo
4 papers
DA
David Alberts
4 papers
Lawrence Flaherty
4 papers

Clinical trials

Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2010–2027
First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
Principal investigator · Terminated · Phase 2
University of Medicine and Dentistry of New Jersey
2006
Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer
Principal investigator · Completed · Phase 2
University of Medicine and Dentistry of New Jersey
2005–2010
Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
Principal investigator · Withdrawn · Phase 2
University of Medicine and Dentistry of New Jersey
2004–2005